Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Nautilus Biotechnology, Inc. (NAUT) had Weighted-Average Shares Outstanding (Diluted) of 126.26M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-59.00M |
|
-- |
|
-- |
|
$66.84M |
|
$-66.84M |
|
$7.84M |
|
$-59.00M |
|
$-59.00M |
|
$-59.00M |
|
$-59.00M |
|
$-59.00M |
|
$-59.00M |
|
$-66.84M |
|
$-61.79M |
|
126.26M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
126.26M |
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$105.96M |
|
$3.46M |
|
$85.15M |
|
$191.11M |
|
$7.95M |
|
-- |
|
$26.19M |
|
$34.14M |
|
$156.97M |
|
$156.97M |
|
$156.97M |
|
126.47M |
|
| Cash Flow Statement Financials | |
$-50.70M |
|
$35.22M |
|
$0.21M |
|
$28.65M |
|
$13.39M |
|
$-15.26M |
|
$6.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-51.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-37.59% |
|
-37.59% |
|
-30.87% |
|
-37.59% |
|
$1.24 |
|
$-0.41 |
|
$-0.40 |
|